S
Stephen V. Faraone
Researcher at State University of New York Upstate Medical University
Publications - 1470
Citations - 155368
Stephen V. Faraone is an academic researcher from State University of New York Upstate Medical University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Bipolar disorder. The author has an hindex of 188, co-authored 1427 publications receiving 140298 citations. Previous affiliations of Stephen V. Faraone include University of Bergen & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Examining the Clinical Correlates of Autism Spectrum Disorder in Youth by Ascertainment Source
Gagan Joshi,Stephen V. Faraone,Janet Wozniak,Carter R. Petty,Carter R. Petty,Ronna Fried,Maribel Galdo,Stephannie L. Furtak,Katie McDermott,Cecily Epstien,Rosemary S. W. Walker,Ashley Caron,Leah Feinberg,Joseph Biederman +13 more
TL;DR: The presentation of ASD in psychiatrically referred youth differs between general and ASD-specialized clinics, though both referral populations have high levels of comorbidity and dysfunction.
Journal ArticleDOI
Differences between attention-deficit disorder with and without hyperactivity: a 1H-magnetic resonance spectroscopy study.
Li Sun,Zhen Jin,Yu-Feng Zang,Ya-Wei Zeng,Gang Liu,Yang Li,Larry J. Seidman,Stephen V. Faraone,Yufeng Wang +8 more
TL;DR: This study demonstrated the existence of measurable difference between children with ADHD-C and ADHD-I using (1)H-MRS.
Journal ArticleDOI
Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention-deficit/hyperactivity disorder.
Jun Li,Chuanyuan Kang,Haobo Zhang,Yufeng Wang,Rulun Zhou,Bing Wang,Lili Guan,Li Yang,Stephen V. Faraone +8 more
TL;DR: Significant associations were observed between the MAOA gene polymorphisms and ADHD remission and these results must be replicated before they can be generalized to other populations.
Journal ArticleDOI
Do Stimulants Reduce the Risk for Cigarette Smoking in Youth with Attention-Deficit Hyperactivity Disorder? A Prospective, Long-Term, Open-Label Study of Extended-Release Methylphenidate
Paul Hammerness,Gagan Joshi,Robert Doyle,Anna M. Georgiopoulos,Daniel A. Geller,Thomas J. Spencer,Carter R. Petty,Stephen V. Faraone,Joseph Biederman +8 more
TL;DR: The smoking rate at endpoint (mean, 10 months of methylphenidate treatment) was low in the clinical trial subjects and not significantly different from that in the non-ADHD comparators or the ADHD comparators receiving stimulants naturalistically (7.1% vs 8.9% as discussed by the authors ).
Journal ArticleDOI
Concurrent validation of schizotaxia: a pilot study.
William S. Stone,William S. Stone,Stephen V. Faraone,Larry J. Seidman,Alan I. Green,Joanne Wojcik,Ming T. Tsuang +6 more
TL;DR: These findings provide the first evidence of concurrent validation for a proposed syndrome of schizotaxia, and are consistent with the view that the vulnerability to schizophrenia may be defined, at least partially, although larger studies will be required to confirm these results.